Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Aug 2026, Sep 2026 and Oct 2026.
- Largest single sale: $851K (11,890 shares) of Ptc Therapeutics, Inc. on Aug 27, 2026. Filing
- Last sale before this period: Jan 8, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Ptc Therapeutics, Inc. (PTCT) | Director | Jun 19, 2013 | Oct 9, 2026 |
| Cytokinetics Inc (CYTK) | Former Director | Apr 29, 2004 | Jun 4, 2010 |
Also a director at
Cytokinetics Inc (CYTK) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 7, 2026, Ptc Therapeutics, Inc.: sold 2,500 shares for $158K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 17, 2026, Ptc Therapeutics, Inc.: sold 10,000 shares for $679K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 16, 2026, Ptc Therapeutics, Inc.: sold 10,000 shares for $671K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 10, 2026, Ptc Therapeutics, Inc.: sold 10,000 shares for $673K, under a disclosed plan (some held indirectly). 1 filing: 1
- Sep 9, 2026, Ptc Therapeutics, Inc.: sold 10,000 shares for $678K, under a disclosed plan (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.